All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CN063 | Anti-ACAA1 (3F11) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3F11 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN064 | Anti-ACAA1 (9E5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 9E5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN065 | Anti-ACAA1 (CL2660) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CL2660 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN066 | Anti-ACAA1 (CL2662) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CL2662 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN067 | Anti-ACAA1 (CL2663) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CL2663 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN164 | Anti-ACAA1 (3F11) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3F11 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN165 | Anti-ACAA1 (9E5) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 9E5 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN166 | Anti-ACAA1 (CL2660) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CL2660 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN167 | Anti-ACAA1 (CL2662) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CL2662 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CN168 | Anti-ACAA1 (CL2663) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CL2663 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION